Proper arranged work station

it is so simple,
look at the picture

it is not only good for eye but also for back, neck, hip, leg and foot pains

Is it helpful ? Sunglasses for Health of Eyes

Sunglasses  protect our eyes from sunlight, as bright light is harmful for eyes.

While purchasing sunglasses don’t remember their actual purpose and do check the ability of glass against UV factor. Sunglasses protect your sensitive eyes from all sorts of bright lights.

Sunglasses are most important tool to guard you against glares while driving. Now it’s recommended to wear sunglasses while driving at day. As it reduce the risk of accidents by improving your vision. Glares are the reflection of sunlight when strikes metal or glass.Otherimportant role of sunglassesis the style statement. A wide range of glasses are available everywhere. Choose accordingly to your face cut, style, personality and age.

As we all know multi-storey buildings and vehicles are made of metals which strongly reflect back light making you unable to see for a moment. Protection of the eyes provided by sunglasses helps you to see clearly and prevents headaches. Special sunglasses are available which reduce glare affect for those who drive mostly. So hurry to buy sunglasses as they minimize the change of accidents due to glare.

Advantages of (GPL) Gas Permeable Lenses

To find the right contact lenses for your eyes it  can be very confusing. There are many varieties out there so it is essential you do your research well and find the best type for your eyes.

One of the lesser well known types of lenses are the gas permeable lenses. These are the most durable of lenses and also come under the name of rigid gas permeable, or oxygen permeable lenses.

Quite often people confuse these lenses with the old fashioned ‘hard’ lenses. These are now obsolete, but the gas permeable have taken their place and are far more reliable. The reason for the confusion is due to the ridged feel of the lenses that make some feel it is a hard lens.

The main reason why these lenses are not the most common is due to the fact that you will have to adapt to the lens far more than you do with a softer lens. Soft lenses are almost instantly comfortable, whereas gas permeable are not. But with time, they become comfortable and ultimately become more reliable.

New treatment for macular degeneration

 November 18, 2011 -- The U.S. Food and Drug Administration approved Eylea (aflibercept) to be used in treatment of patients with wet (neovascular) age-related macular degeneration (AMD), which is one of major causes of vision loss and blindness in ages 60 and older.

AMD gradually destroys a person’s sharp, central vision. It affects the macula, the part of the eye that allows people to see fine detail needed to do daily tasks such as reading and driving.

There are two forms of AMD, a wet form and a dry form. The wet form of AMD includes the growth of abnormal blood vessels. The blood vessels can leak fluid into the central part of the retina, also known as the macula. When fluid leaks into the macula, the macula thickens and vision loss occurs. An early symptom of wet AMD occurs when straight lines appear to be wavy.

“Eylea is an important new treatment option for adults with wet AMD,” said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in FDA’s Center for Drug Evaluation and Research. “It is a potentially blinding disease and the availability of new treatment options is important.”

The safety and effectiveness of Eylea was evaluated in two clinical trials involving 2,412 adult patients. People in the study received either Eylea or Lucentis (ranibizumab injection). The primary endpoint in each study was a patient’s clearness of vision (visual acuity) after one year of treatment.

Eylea is injected into the eye either every four weeks or every eight weeks by an ophthalmologist. The studies showed that Eylea was as effective as Lucentis in maintaining or improving visual acuity.

The most commonly reported side effects in patients receiving Eylea included eye pain, blood at the injection site (conjunctival hemorrhage), the appearance of floating spots in a person’s vision (vitreous floaters), clouding of the eye lens (cataract), and an increase in eye pressure.

Eylea should not be used in those who have an active eye infection or active ocular inflammation. Eylea has not been studied in pregnant women, so the treatment should be used only in pregnant women if the potential benefits of the treatment outweigh any potential risks. Age related macular degeneration does not occur in children and Eylea has not been studied in children.

Other FDA-approved treatment options for wet AMD include: Visudyne (verteporfin for injection) approved in 2000, Macugen (pegaptanib sodium injection) approved in 2004, and Lucentis (ranibizumab injection) approved in 2006.

Eylea is marketed by Tarrytown